Haemonetics

HAE · NYSE🇺🇸

Overview

Earnings Dividends Seasonality Metrics

FEB

5

Q3 2026

Reported

Reported earnings 2 days ago

Adjusted gross margin

Previous year: $29.6M

+150.7%

Total Assets

$2.49B

Previous year: $2.53B

-1.6%

Loading...

Haemonetics

Unlock previous datapoints

Upgrade

Haemonetics

Unlock previous datapoints

Upgrade

Haemonetics Revenue by Segment

Revenue by Segment

Plasma Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Blood Center Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Hospital Revenue

Unlock previous datapoints

Upgrade

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$3.12B

P/E Ratio

15.77

Sector

N/A

Industry

N/A

52-Week High

$86.9

52-Week Low

$47.6

Gross margin

59.7%

Adjusted gross margin

60.2%

Operating margin

19.9%

Adjusted operating margin

26.3%

Revenue decrease

-3%

Products

Get in Touch

Resources

Haemonetics

Haemonetics

Haemonetics

Haemonetics Revenue by Segment

Revenue by Segment

Plasma Revenue

Blood Center Revenue

Hospital Revenue

Revenue & Expenses

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics